Shelter Pharma Limited has officially announced the commercial availability of its new fitness supplement FitKick Pro in the domestic market. The company informed stock exchanges that the product, which was initially announced on 02nd February, 2026, is now successfully launched and commercially available from 30th March, 2026.

Product Launch Details

The fitness supplement is now available across various channels including reputed online platforms such as Amazon. The company has positioned FitKick Pro as a comprehensive fitness supplement designed to enhance workout performance and user experience.

Product Features and Benefits

FitKick Pro offers multiple fitness-focused benefits designed to support workout routines and athletic performance. The supplement has been developed to address various aspects of fitness and exercise enhancement.

Key product features include:

• Improved Endurance: Enhanced stamina for extended workout sessions
• Enhanced Focus: Better concentration during training
• Muscle Pump: Support for muscle engagement during exercises
• Delicious Flavors: Appealing taste profiles for better user experience

Market Strategy and Future Plans

Currently, FitKick Pro caters exclusively to the domestic market, allowing Shelter Pharma to establish a strong foundation in the Indian fitness supplement sector. The company has indicated that it may explore opportunities in international markets in due course, suggesting potential expansion plans for the product line.

Regulatory Compliance

The announcement was made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring proper disclosure of material events to stakeholders. The company has maintained transparency by providing detailed information about the product launch timeline and market positioning.

The successful launch of FitKick Pro represents Shelter Pharma's continued expansion into the fitness and wellness segment, complementing its existing pharmaceutical portfolio with consumer-focused health products.

Shelter Pharma Limited has successfully completed a third-party food safety audit under the Food Safety and Standards Authority of India (FSSAI) regulatory framework, achieving exceptional results that underscore the company's commitment to quality and safety standards.

Audit Results and Performance

The manufacturing facility of Shelter Pharma Limited underwent a comprehensive evaluation by an FSSAI-recognized third-party auditing agency. The audit was designed to assess compliance with applicable food safety standards and regulatory requirements across the company's operations.

Compliance and Quality Standards

The audit results demonstrate Shelter Pharma's strong adherence to prescribed food safety management systems and operational standards. The A+ rating reflects the facility's comprehensive compliance with FSSAI requirements and indicates the company's robust quality control measures.

The evaluation covered various aspects of food safety protocols, including:

• Manufacturing processes and procedures
• Quality control systems
• Regulatory compliance frameworks
• Operational safety standards

Regulatory Disclosure

Shelter Pharma Limited made this disclosure pursuant to Regulation 30 read with Schedule III – Part A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company informed the Bombay Stock Exchange Limited about the audit completion and results on March 18, 2026.

The successful audit outcome reinforces Shelter Pharma's dedication to maintaining high standards of quality and food safety in its products, positioning the company favorably within the regulatory compliance landscape.